APA (7th ed.) Citation

Coyle, L., Gallagher, C., Kukla, L., Paliga, R., Siemeck, R., Yost, G., . . . Tatooles, A. (2020). Two-Year Outcomes in HeartMate 3 versus HeartWare HVAD Patients Implanted as Destination Therapy. Journal of Heart & Lung Transplantation, 39(4), S411. https://doi.org/10.1016/j.healun.2020.01.173

Chicago Style (17th ed.) Citation

Coyle, L., C. Gallagher, L. Kukla, R. Paliga, R. Siemeck, G. Yost, M. Dia, and A. Tatooles. "Two-Year Outcomes in HeartMate 3 Versus HeartWare HVAD Patients Implanted as Destination Therapy." Journal of Heart & Lung Transplantation 39, no. 4 (2020): S411. https://doi.org/10.1016/j.healun.2020.01.173.

MLA (9th ed.) Citation

Coyle, L., et al. "Two-Year Outcomes in HeartMate 3 Versus HeartWare HVAD Patients Implanted as Destination Therapy." Journal of Heart & Lung Transplantation, vol. 39, no. 4, 2020, p. S411, https://doi.org/10.1016/j.healun.2020.01.173.